HIV-1包膜糖蛋白gp41广泛中和抗体：疫苗开发的障碍 - Suppr

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.

作者信息

Verkoczy Laurent, Kelsoe Garnett, Haynes Barton F

机构信息

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Pathology, Duke University School of Medicine, Durham, North Carolina, United States of America.

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Immunology, Duke University School of Medicine, Durham, North Carolina, United States of America.

出版信息

PLoS Pathog. 2014 May 22;10(5):e1004073. doi: 10.1371/journal.ppat.1004073. eCollection 2014 May.

DOI:10.1371/journal.ppat.1004073

PMID:24853821

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4031215/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38d/4031215/8e5ca9ba5d88/ppat.1004073.g001.jpg

相似文献

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.

PLoS Pathog. 2014 May 22;10(5):e1004073. doi: 10.1371/journal.ppat.1004073. eCollection 2014 May.

HIV. The modern era of HIV-1 vaccine development.

Science. 2015 Jul 10;349(6244):139-40. doi: 10.1126/science.aac7800.

Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.

PLoS One. 2011;6(5):e14813. doi: 10.1371/journal.pone.0014813. Epub 2011 May 19.

Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity.

EBioMedicine. 2016 Oct;12:196-207. doi: 10.1016/j.ebiom.2016.08.045. Epub 2016 Aug 31.

Immunology. Close to the edge: neutralizing the HIV-1 envelope.

Science. 2005 Jun 24;308(5730):1878-9. doi: 10.1126/science.1114854.

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

Science. 2005 Jun 24;308(5730):1906-8. doi: 10.1126/science.1111781. Epub 2005 Apr 28.

Neutralizing antibodies to HIV-1 induced by immunization.

J Exp Med. 2013 Feb 11;210(2):209-23. doi: 10.1084/jem.20121827.

Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.

AIDS Res Hum Retroviruses. 2018 Apr;34(4):365-374. doi: 10.1089/AID.2017.0250. Epub 2018 Jan 25.

N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies.

Virol Sin. 2015 Dec;30(6):449-56. doi: 10.1007/s12250-015-3664-6. Epub 2015 Dec 21.

Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.

Curr Opin Immunol. 2011 Jun;23(3):383-90. doi: 10.1016/j.coi.2011.04.003. Epub 2011 Apr 27.

引用本文的文献

Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.

J Virol. 2023 Jan 31;97(1):e0164722. doi: 10.1128/jvi.01647-22. Epub 2022 Dec 21.

Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies.

Viruses. 2021 Jan 19;13(1):134. doi: 10.3390/v13010134.

Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies.

Elife. 2021 Jan 11;10:e63444. doi: 10.7554/eLife.63444.

Neutralizing Antibodies Targeting HIV-1 gp41.

Viruses. 2020 Oct 23;12(11):1210. doi: 10.3390/v12111210.

An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice.

Ann Biomed Eng. 2020 Jul;48(7):1991-2001. doi: 10.1007/s10439-019-02398-8. Epub 2019 Dec 12.

Strategies for inducing effective neutralizing antibody responses against HIV-1.

Expert Rev Vaccines. 2019 Nov;18(11):1127-1143. doi: 10.1080/14760584.2019.1690458. Epub 2019 Dec 2.

The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects.

Protein Cell. 2018 Jul;9(7):596-615. doi: 10.1007/s13238-018-0534-7. Epub 2018 Apr 17.

Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?

AIMS Public Health. 2015 May 6;2(2):183-193. doi: 10.3934/publichealth.2015.2.183. eCollection 2015.

Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions.

J Virol. 2018 Mar 28;92(8). doi: 10.1128/JVI.02249-17. Print 2018 Apr 15.

Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target.

Front Immunol. 2017 Sep 19;8:1154. doi: 10.3389/fimmu.2017.01154. eCollection 2017.

本文引用的文献

Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.

J Immunol. 2014 Feb 15;192(4):1693-706. doi: 10.4049/jimmunol.1302511. Epub 2014 Jan 24.

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

Nature. 2013 Nov 14;503(7475):224-8. doi: 10.1038/nature12744. Epub 2013 Oct 30.

Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10.

PLoS Pathog. 2013;9(9):e1003639. doi: 10.1371/journal.ppat.1003639. Epub 2013 Sep 26.

Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10.

J Immunol. 2013 Sep 15;191(6):3186-3191. doi: 10.4049/jimmunol.1301285. Epub 2013 Aug 12.

B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates.

J Immunol. 2013 Sep 15;191(6):3179-85. doi: 10.4049/jimmunol.1301283. Epub 2013 Aug 12.

Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses.

J Immunol. 2013 Sep 1;191(5):2538-50. doi: 10.4049/jimmunol.1300971. Epub 2013 Aug 5.

Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10.

J Immunol. 2013 Aug 1;191(3):1260-75. doi: 10.4049/jimmunol.1300770. Epub 2013 Jul 3.

HIV-1 neutralizing antibodies: understanding nature's pathways.

Immunol Rev. 2013 Jul;254(1):225-44. doi: 10.1111/imr.12075.

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus.

Nature. 2013 Apr 25;496(7446):469-76. doi: 10.1038/nature12053. Epub 2013 Apr 3.

Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.

Cell. 2013 Mar 28;153(1):126-38. doi: 10.1016/j.cell.2013.03.018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献